BODi’s CEO Says AI Won’t Complicate Active Nutrition
BODi CEO Carl Daikeler says active nutrition simplicity is the strategy, even as AI, GLP-1 drugs, and longevity trends reshape consumer expectations.
BODi CEO Carl Daikeler says active nutrition simplicity is the strategy, even as AI, GLP-1 drugs, and longevity trends reshape consumer expectations.